Skip to main content

Peer Review reports

From: Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection

Original Submission
25 Jun 2018 Submitted Original manuscript
18 Jul 2018 Reviewed Reviewer Report - Paul Phelan
12 Sep 2018 Author responded Author comments - Gastón Piñeiro
Resubmission - Version 2
12 Sep 2018 Submitted Manuscript version 2
21 Sep 2018 Author responded Author comments - Gastón Piñeiro
Resubmission - Version 3
21 Sep 2018 Submitted Manuscript version 3
Publishing
24 Sep 2018 Editorially accepted
11 Oct 2018 Article published 10.1186/s12882-018-1057-4

You can find further information about peer review here.

Back to article page